The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • No Criteria Specification was provided in the publication event for the variant classifaction.
  • The Criteria Specification shown below is a best-estimate based on the VCEP, gene, disease, and publication date.

Variant: NM_001754.5(RUNX1):c.1020C>G (p.Pro340=)

CA512341366

758049 (ClinVar)

Gene: RUNX1 (HGNC:861)
Condition: hereditary thrombocytopenia and hematologic cancer predisposition syndrome (MONDO:0011071)
Inheritance Mode: Autosomal dominant inheritance
UUID: 95d282c7-2a56-469b-b26c-ecde2f514069
Approved on: 2022-01-20
Published on: 2022-06-30

HGVS expressions

NM_001754.5:c.1020C>G
NM_001754.5(RUNX1):c.1020C>G (p.Pro340=)
NC_000021.9:g.34792558G>C
CM000683.2:g.34792558G>C
NC_000021.8:g.36164855G>C
CM000683.1:g.36164855G>C
NC_000021.7:g.35086725G>C
NG_011402.2:g.1197154C>G
ENST00000675419.1:c.1020C>G
ENST00000300305.7:c.1020C>G
ENST00000344691.8:c.939C>G
ENST00000399240.5:c.747C>G
ENST00000437180.5:c.1020C>G
ENST00000482318.5:c.*610C>G
NM_001001890.2:c.939C>G
NM_001754.4:c.1020C>G
NM_001001890.3:c.939C>G
More

Likely Benign

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Conflicting Evidence"
Met criteria codes 3
BP4 BP7 PM2_Supporting
Not Met criteria codes 23
PM5 PM1 PM3 PM4 PM6 BS2 BS4 BS3 BS1 PVS1 PS4 PS2 PS1 PS3 BP2 BP3 BP1 BP5 BA1 PP1 PP4 PP3 PP2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Myeloid Malignancy VCEP
This variant NM_001754.5(RUNX1):c.1020C>G (p.Pro340=) is a synonymous variant. As it is a synonymous variant there is no REVEL score but SpliceAI is ≤0.20 (0.00) (BP4). The PhyloP Score is <2.0 (-0.628) (BP7). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_supporting). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4, BP7, PM2_supporting.
Met criteria codes
BP4
Synonymous variant, therefore, has no REVEL score but SpliceAI is ≤0.20 (0.00)
BP7
PhyloP Score is <2.0 (-0.628)
PM2_Supporting
This variant is completely absent from all population databases with at least 20x coverage for RUNX1.
Not Met criteria codes
PM5
Synonymous variant does not meet PM5
PM1
Synonymous variant outside of hotspot/ critical domain
PM3
This rule is not applicable for MM-VCEP
PM4
Synonymous variant does not meet PM4
PM6
No case studies found
BS2
This rule is not applicable for MM-VCEP
BS4
No case studies found
BS3
No functional studies found
BS1
Meets PM2.
PVS1
Synonymous variant does not meet PVS1
PS4
No case studies found
PS2
No case studies found
PS1
Amino acid (proline) at 340 change has not been recorded as pathogenic.
PS3
No functional studies found
BP2
No homozygotes reported in gnomAD
BP3
This rule is not applicable for MM-VCEP
BP1
This rule is not applicable for MM-VCEP
BP5
This rule is not applicable for MM-VCEP
BA1
Meets PM2.
PP1
No case studies found
PP4
This rule is not applicable for MM-VCEP
PP3
Synonymous variant, therefore, does not have a REVEl score and SpliceAI is not ≥0.38 (0.00)
PP2
This rule is not applicable for MM-VCEP
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.